Brain Neurotherapy Bio, Inc.
🇺🇸United States
- Country
- 🇺🇸United States
- Ownership
- Subsidiary
- Established
- 2018-01-01
- Employees
- 11
- Market Cap
- -
- Website
- https://www.brainneubio.com
GDNF Gene Therapy for Multiple System Atrophy
Phase 1
Recruiting
- Conditions
- Multiple System Atrophy
- Interventions
- Biological: AAV2-GDNF gene therapyProcedure: Sham (Placebo) Surgery
- First Posted Date
- 2020-12-22
- Last Posted Date
- 2024-10-02
- Lead Sponsor
- Brain Neurotherapy Bio, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT04680065
- Locations
- 🇺🇸
NYU Langone Health, New York, New York, United States
🇺🇸University of California Irvine, Irvine, California, United States
🇺🇸Parkinson's Disease and Movement Disorders Center of Boca Raton, Boca Raton, Florida, United States
GDNF Gene Therapy for Parkinson's Disease
Phase 1
Active, not recruiting
- Conditions
- Parkinson's Disease
- Interventions
- Biological: AAV2-GDNF
- First Posted Date
- 2019-11-19
- Last Posted Date
- 2024-08-13
- Lead Sponsor
- Brain Neurotherapy Bio, Inc.
- Target Recruit Count
- 11
- Registration Number
- NCT04167540
- Locations
- 🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸University of California Irvine, Irvine, California, United States
🇺🇸The Ohio State University Medical Center, Columbus, Ohio, United States
© Copyright 2025. All Rights Reserved by MedPath